Literature DB >> 4130153

The utilization of properdin in the alternate pathway of complement activation: isolation of properdin convertase.

A E Stitzel, R E Spitzer.   

Abstract

Mesh：

Substances：

Year:  1974        PMID： 4130153

Source DB:  PubMed          Journal:  J Immunol        ISSN： 0022-1767            Impact factor:   5.422


× No keyword cloud information.
  6 in total

1.  The effect of anticomplementary substances on properdin in normal and C2-deficient sera.

Authors:  R H McLean; K Townsend; A F Michael
Journal:  Clin Exp Immunol       Date:  1975-03       Impact factor: 4.330

2.  The cofactors required by C3 nephritic factor to generate a C3 convertase in vitro.

Authors:  N Amos; J G Sissons; J F Girard; P J Lachmann; D K Peters
Journal:  Clin Exp Immunol       Date:  1976-06       Impact factor: 4.330

3.  Binding of activated properdin to untreated erythrocytes: a new function of activated properdin.

Authors:  T Konno; H Hirai; N Tamura
Journal:  Immunology       Date:  1978-02       Impact factor: 7.397

4.  Immunologic defect of the alternate pathway-of-complement activation postsplenectomy: a possible relation between splenectomy and infection.

Authors:  A de Ciutiis; M J Polley; L J Metakis; C M Peterson
Journal:  J Natl Med Assoc       Date:  1978-09       Impact factor: 1.798

5.  Metabolism of properdin in normal subjects and patients with renal disease.

Authors:  J B Ziegler; F S Rosen; C A Alper; W Grupe; I H Lepow
Journal:  J Clin Invest       Date:  1975-09       Impact factor: 14.808

6.  Alternative pathway of complement: recruitment of precursor properdin by the labile C3/C5 convertase and the potentiation of the pathway.

Authors:  R G Medicus; O Götze; H J Müller-Eberhard
Journal:  J Exp Med       Date:  1976-10-01       Impact factor: 14.307
  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.